Although the specific ligands under conditions of NAFLD‐NASH in activating the MD2‐TLR4 have yet to be identified, our data obtained from HepG2 cells indicated that PA is likely one contributing TLR4 ligand. This evidence concerns the gene LY96 and metabolic dysfunction-associated steatohepatitis.